Skip to content
value.today

MitoGenetics, LLC

Total raised
$4 M
2 rounds on record
Latest round
$2 M
Nov 2014
First round on record
Jun 2013
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of MitoGenetics, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2014$2 MNo. 2$2 to $10 million

MitoGenetics, LLC: Raise no. 2, Nov 2014

Investors in this round

99 investors had bought by the notice of May 2, 2016: 99 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
$11,000
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Iowa

People named in the notice

  • Brad Saeger · Executive Officer, Director
  • Brian Minish · Executive Officer
  • George Charles Stefano · Executive Officer, Director
  • Isaac Tessmer · Executive Officer, Director
  • Marcia Hendrickson · Executive Officer, Director
  • Nick Sershen · Executive Officer
  • William Switzer · Executive Officer, Director
  • E. Charles Brice · Director
  • Mark Graczynski · Director
  • Max Charles Rogers · Director
  • Walt Bones · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Marcia Hendrickson, President. Source: SEC Form D, newest notice filed May 2, 2016. Read the notice at the SEC.

equitySEC
Jun 2013$1 MNo. 1Under $2 million

MitoGenetics, LLC: Raise no. 1, Jun 2013

Investors in this round

47 investors had bought by the notice of Mar 3, 2014: 47 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $5 M offered; $4 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Iowa

People named in the notice

  • Evan W. Rayl · Executive Officer, Director
  • Isaac J. Tessmer · Executive Officer, Director
  • Ivan W. Paulson · Executive Officer, Director
  • Leon J. Schwartz · Executive Officer, Director
  • Marcia Hendrickson · Executive Officer, Director
  • Steve W. Sershen · Executive Officer
  • William W. Switzer · Executive Officer, Director
  • Brad W. Nelson · Director
  • Mark W. Atwood · Director
  • Mark W. Graczynski · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Marcia Hendrickson, President/CEO. Source: SEC Form D, newest notice filed Mar 3, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • MitoGenetics, LLC chose not to state its revenue in its newest notice of a funding round (May 2016).

    SEC Form D · May 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2016

That is all the official record says: MitoGenetics, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of MitoGenetics, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 99 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by MitoGenetics, LLC
NameRoleNamed in
Brad SaegerExecutive officerMay 2016
Brian MinishExecutive officerMay 2016
George Charles StefanoExecutive officerMay 2016
Isaac TessmerExecutive officerMay 2016
Marcia HendricksonExecutive officerMay 2016
Nick SershenExecutive officerMay 2016
William SwitzerExecutive officerMay 2016
Evan W. RaylExecutive officerMar 2014
Isaac J. TessmerExecutive officerMar 2014
Ivan W. PaulsonExecutive officerMar 2014
Leon J. SchwartzExecutive officerMar 2014
Steve W. SershenExecutive officerMar 2014
William W. SwitzerExecutive officerMar 2014
Brad SaegerDirectorMay 2016
E. Charles BriceDirectorMay 2016
George Charles StefanoDirectorMay 2016
Isaac TessmerDirectorMay 2016
Marcia HendricksonDirectorMay 2016
Mark GraczynskiDirectorMay 2016
Max Charles RogersDirectorMay 2016
Walt BonesDirectorMay 2016
William SwitzerDirectorMay 2016
Brad W. NelsonDirectorMar 2014
Evan W. RaylDirectorMar 2014
Isaac J. TessmerDirectorMar 2014
Ivan W. PaulsonDirectorMar 2014
Leon J. SchwartzDirectorMar 2014
Mark W. AtwoodDirectorMar 2014
Mark W. GraczynskiDirectorMar 2014
William W. SwitzerDirectorMar 2014